PCT Europe 2017, Amsterdam. In partnership with Synergy CRO, Cyntegrity presents the concept of #RealRBM: Hype or Common Sense. The main topics of the presentation are: The concept of integrity in Risk-based Monitoring Risks perception - differences in risk assessment between a sponsor and a CRO [...]
Interested in holistic implementation of the RBM? Let's talk in London by Clinical Operations Strategy Meeting (EU 2016) on Monday 11th July 2016. See the RBM session plan for the meeting: Interested in scheduling a meeting during the conference or after?[button link="https://cyntegrity.com/contact-info/" color="default" size="" stretch="" type="" shape="" [...]
PCT Europe is back for 2018, bringing you the latest information from across the clinical trials spectrum and providing you with direct access to the industry’s leading innovators.
Our CEO, Dr Artem Andrianov, will share his industry insights and expertise as one of the selected key note speakers. We hope your busy schedule will allow you to meet with Artem.
The Society for Clinical Data Management (SCDM) is a non-profit, international organization.
The dramatic expansion of prescription drug deaths inspired this year's theme "driving insights to action". Insights that could be deployed through novel disruptive technologies such as Risk-based Quality Management (RBQM). Cyntegrity's Johann Proeve and Nimita Limaye were in Boston and share their observations with us.
Cyntegrity today announced the worldwide release of their Medical Device RACT, “MD-RACT”, the world’s first Risk Assessment and Categorization Tool for clinical investigations, that combines the best practices in Life Sciences with subject matter expertise in Medical Devices.
DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide.
The ninth German ePharma Day will be taking place in Frankfurt am Main on Tuesday, June 19th, 2018. This year's theme will be "Future perspective in Clinical Research: are you ready for the next decade?". Our CEO, Dr Artem Andrianov, will be one of the selected speakers and elaborate on the interesting Evolution of RBM - Risk Based Quality Management from 12:10 - 12:50.
The EU MDR is setting the stage for busy times ahead. The continuous need for clinical evidence, the increasing complexity of new medical devices, and the size and global nature of medical device trials introduce a greater potential for error. Learn how a risk-based approach enables MedTech manufacturers to better understand, manage and mitigate the growing uncertainties.